Report Detail

Pharma & Healthcare Global In-Vitro Toxicity Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM3843757
  • |
  • 02 August, 2024
  • |
  • Global
  • |
  • 109 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global In-Vitro Toxicity Testing market size was valued at USD 10180 million in 2023 and is forecast to a readjusted size of USD 17010 million by 2030 with a CAGR of 7.6% during review period.
In vitro toxicity testing is the scientific analysis of the effects of toxic chemical substances on cultured bacteria or mammalian cells. In vitro testing methods are employed primarily to identify potentially hazardous chemicals and/or to confirm the lack of certain toxic properties in the early stages of the development of potentially useful new substances such as therapeutic drugs, agricultural chemicals and food additives.
A significant driver in the In-Vitro Toxicity Testing market is the increasing focus on alternatives to traditional animal testing methods in pharmaceutical and chemical industries. In-Vitro toxicity testing offers a more ethical and cost-effective approach to assess the safety and toxicity of chemicals and drugs. However, a notable challenge in this market is the need for regulatory acceptance and standardization of in-vitro testing methods. Ensuring that in-vitro tests gain regulatory approval and are universally recognized as accurate predictors of toxicity poses a significant challenge. Manufacturers and regulatory bodies must collaborate to establish robust validation processes and harmonized guidelines to facilitate the wider adoption of in-vitro toxicity testing while ensuring the safety of products and environmental protection.
The Global Info Research report includes an overview of the development of the In-Vitro Toxicity Testing industry chain, the market status of Pharmaceuticals & Biopharmaceuticals (Cell Culture Technologies, High-throughput Technologies), Cosmetic & Household Products (Cell Culture Technologies, High-throughput Technologies), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of In-Vitro Toxicity Testing.
Regionally, the report analyzes the In-Vitro Toxicity Testing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global In-Vitro Toxicity Testing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the In-Vitro Toxicity Testing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the In-Vitro Toxicity Testing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Cell Culture Technologies, High-throughput Technologies).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the In-Vitro Toxicity Testing market.
Regional Analysis: The report involves examining the In-Vitro Toxicity Testing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the In-Vitro Toxicity Testing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to In-Vitro Toxicity Testing:
Company Analysis: Report covers individual In-Vitro Toxicity Testing players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards In-Vitro Toxicity Testing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceuticals & Biopharmaceuticals, Cosmetic & Household Products).
Technology Analysis: Report covers specific technologies relevant to In-Vitro Toxicity Testing. It assesses the current state, advancements, and potential future developments in In-Vitro Toxicity Testing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the In-Vitro Toxicity Testing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
In-Vitro Toxicity Testing market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Cell Culture Technologies
High-throughput Technologies
Toxicogenomics
Market segment by Application
Pharmaceuticals & Biopharmaceuticals
Cosmetic & Household Products
Food
Chemicals
Market segment by players, this report covers
Thermo Fisher Scientific
Covance
Bio-Rad Laboratories
GE Healthcare
Eurofins Scientific
Merck KGaA
Charles River Laboratories
Catalent
Cyprotex
QIAGEN
Promega
Gentronix
BioIVT
MB Research Laboratories
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe In-Vitro Toxicity Testing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of In-Vitro Toxicity Testing, with revenue, gross margin and global market share of In-Vitro Toxicity Testing from 2019 to 2024.
Chapter 3, the In-Vitro Toxicity Testing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and In-Vitro Toxicity Testing market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of In-Vitro Toxicity Testing.
Chapter 13, to describe In-Vitro Toxicity Testing research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of In-Vitro Toxicity Testing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of In-Vitro Toxicity Testing by Type
    • 1.3.1 Overview: Global In-Vitro Toxicity Testing Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global In-Vitro Toxicity Testing Consumption Value Market Share by Type in 2023
    • 1.3.3 Cell Culture Technologies
    • 1.3.4 High-throughput Technologies
    • 1.3.5 Toxicogenomics
  • 1.4 Global In-Vitro Toxicity Testing Market by Application
    • 1.4.1 Overview: Global In-Vitro Toxicity Testing Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Pharmaceuticals & Biopharmaceuticals
    • 1.4.3 Cosmetic & Household Products
    • 1.4.4 Food
    • 1.4.5 Chemicals
  • 1.5 Global In-Vitro Toxicity Testing Market Size & Forecast
  • 1.6 Global In-Vitro Toxicity Testing Market Size and Forecast by Region
    • 1.6.1 Global In-Vitro Toxicity Testing Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global In-Vitro Toxicity Testing Market Size by Region, (2019-2030)
    • 1.6.3 North America In-Vitro Toxicity Testing Market Size and Prospect (2019-2030)
    • 1.6.4 Europe In-Vitro Toxicity Testing Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific In-Vitro Toxicity Testing Market Size and Prospect (2019-2030)
    • 1.6.6 South America In-Vitro Toxicity Testing Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East and Africa In-Vitro Toxicity Testing Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Thermo Fisher Scientific
    • 2.1.1 Thermo Fisher Scientific Details
    • 2.1.2 Thermo Fisher Scientific Major Business
    • 2.1.3 Thermo Fisher Scientific In-Vitro Toxicity Testing Product and Solutions
    • 2.1.4 Thermo Fisher Scientific In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Thermo Fisher Scientific Recent Developments and Future Plans
  • 2.2 Covance
    • 2.2.1 Covance Details
    • 2.2.2 Covance Major Business
    • 2.2.3 Covance In-Vitro Toxicity Testing Product and Solutions
    • 2.2.4 Covance In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Covance Recent Developments and Future Plans
  • 2.3 Bio-Rad Laboratories
    • 2.3.1 Bio-Rad Laboratories Details
    • 2.3.2 Bio-Rad Laboratories Major Business
    • 2.3.3 Bio-Rad Laboratories In-Vitro Toxicity Testing Product and Solutions
    • 2.3.4 Bio-Rad Laboratories In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Bio-Rad Laboratories Recent Developments and Future Plans
  • 2.4 GE Healthcare
    • 2.4.1 GE Healthcare Details
    • 2.4.2 GE Healthcare Major Business
    • 2.4.3 GE Healthcare In-Vitro Toxicity Testing Product and Solutions
    • 2.4.4 GE Healthcare In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 GE Healthcare Recent Developments and Future Plans
  • 2.5 Eurofins Scientific
    • 2.5.1 Eurofins Scientific Details
    • 2.5.2 Eurofins Scientific Major Business
    • 2.5.3 Eurofins Scientific In-Vitro Toxicity Testing Product and Solutions
    • 2.5.4 Eurofins Scientific In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Eurofins Scientific Recent Developments and Future Plans
  • 2.6 Merck KGaA
    • 2.6.1 Merck KGaA Details
    • 2.6.2 Merck KGaA Major Business
    • 2.6.3 Merck KGaA In-Vitro Toxicity Testing Product and Solutions
    • 2.6.4 Merck KGaA In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Merck KGaA Recent Developments and Future Plans
  • 2.7 Charles River Laboratories
    • 2.7.1 Charles River Laboratories Details
    • 2.7.2 Charles River Laboratories Major Business
    • 2.7.3 Charles River Laboratories In-Vitro Toxicity Testing Product and Solutions
    • 2.7.4 Charles River Laboratories In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Charles River Laboratories Recent Developments and Future Plans
  • 2.8 Catalent
    • 2.8.1 Catalent Details
    • 2.8.2 Catalent Major Business
    • 2.8.3 Catalent In-Vitro Toxicity Testing Product and Solutions
    • 2.8.4 Catalent In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Catalent Recent Developments and Future Plans
  • 2.9 Cyprotex
    • 2.9.1 Cyprotex Details
    • 2.9.2 Cyprotex Major Business
    • 2.9.3 Cyprotex In-Vitro Toxicity Testing Product and Solutions
    • 2.9.4 Cyprotex In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Cyprotex Recent Developments and Future Plans
  • 2.10 QIAGEN
    • 2.10.1 QIAGEN Details
    • 2.10.2 QIAGEN Major Business
    • 2.10.3 QIAGEN In-Vitro Toxicity Testing Product and Solutions
    • 2.10.4 QIAGEN In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 QIAGEN Recent Developments and Future Plans
  • 2.11 Promega
    • 2.11.1 Promega Details
    • 2.11.2 Promega Major Business
    • 2.11.3 Promega In-Vitro Toxicity Testing Product and Solutions
    • 2.11.4 Promega In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Promega Recent Developments and Future Plans
  • 2.12 Gentronix
    • 2.12.1 Gentronix Details
    • 2.12.2 Gentronix Major Business
    • 2.12.3 Gentronix In-Vitro Toxicity Testing Product and Solutions
    • 2.12.4 Gentronix In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.12.5 Gentronix Recent Developments and Future Plans
  • 2.13 BioIVT
    • 2.13.1 BioIVT Details
    • 2.13.2 BioIVT Major Business
    • 2.13.3 BioIVT In-Vitro Toxicity Testing Product and Solutions
    • 2.13.4 BioIVT In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.13.5 BioIVT Recent Developments and Future Plans
  • 2.14 MB Research Laboratories
    • 2.14.1 MB Research Laboratories Details
    • 2.14.2 MB Research Laboratories Major Business
    • 2.14.3 MB Research Laboratories In-Vitro Toxicity Testing Product and Solutions
    • 2.14.4 MB Research Laboratories In-Vitro Toxicity Testing Revenue, Gross Margin and Market Share (2019-2024)
    • 2.14.5 MB Research Laboratories Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global In-Vitro Toxicity Testing Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of In-Vitro Toxicity Testing by Company Revenue
    • 3.2.2 Top 3 In-Vitro Toxicity Testing Players Market Share in 2023
    • 3.2.3 Top 6 In-Vitro Toxicity Testing Players Market Share in 2023
  • 3.3 In-Vitro Toxicity Testing Market: Overall Company Footprint Analysis
    • 3.3.1 In-Vitro Toxicity Testing Market: Region Footprint
    • 3.3.2 In-Vitro Toxicity Testing Market: Company Product Type Footprint
    • 3.3.3 In-Vitro Toxicity Testing Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global In-Vitro Toxicity Testing Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global In-Vitro Toxicity Testing Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global In-Vitro Toxicity Testing Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global In-Vitro Toxicity Testing Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America In-Vitro Toxicity Testing Consumption Value by Type (2019-2030)
  • 6.2 North America In-Vitro Toxicity Testing Consumption Value by Application (2019-2030)
  • 6.3 North America In-Vitro Toxicity Testing Market Size by Country
    • 6.3.1 North America In-Vitro Toxicity Testing Consumption Value by Country (2019-2030)
    • 6.3.2 United States In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 6.3.3 Canada In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe In-Vitro Toxicity Testing Consumption Value by Type (2019-2030)
  • 7.2 Europe In-Vitro Toxicity Testing Consumption Value by Application (2019-2030)
  • 7.3 Europe In-Vitro Toxicity Testing Market Size by Country
    • 7.3.1 Europe In-Vitro Toxicity Testing Consumption Value by Country (2019-2030)
    • 7.3.2 Germany In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 7.3.3 France In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 7.3.5 Russia In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 7.3.6 Italy In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific In-Vitro Toxicity Testing Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific In-Vitro Toxicity Testing Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific In-Vitro Toxicity Testing Market Size by Region
    • 8.3.1 Asia-Pacific In-Vitro Toxicity Testing Consumption Value by Region (2019-2030)
    • 8.3.2 China In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 8.3.3 Japan In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 8.3.5 India In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 8.3.7 Australia In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America In-Vitro Toxicity Testing Consumption Value by Type (2019-2030)
  • 9.2 South America In-Vitro Toxicity Testing Consumption Value by Application (2019-2030)
  • 9.3 South America In-Vitro Toxicity Testing Market Size by Country
    • 9.3.1 South America In-Vitro Toxicity Testing Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa In-Vitro Toxicity Testing Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa In-Vitro Toxicity Testing Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa In-Vitro Toxicity Testing Market Size by Country
    • 10.3.1 Middle East & Africa In-Vitro Toxicity Testing Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)
    • 10.3.4 UAE In-Vitro Toxicity Testing Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 In-Vitro Toxicity Testing Market Drivers
  • 11.2 In-Vitro Toxicity Testing Market Restraints
  • 11.3 In-Vitro Toxicity Testing Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 In-Vitro Toxicity Testing Industry Chain
  • 12.2 In-Vitro Toxicity Testing Upstream Analysis
  • 12.3 In-Vitro Toxicity Testing Midstream Analysis
  • 12.4 In-Vitro Toxicity Testing Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on In-vitro Toxicity Testing. Industry analysis & Market Report on In-vitro Toxicity Testing is a syndicated market report, published as Global In-Vitro Toxicity Testing Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of In-vitro Toxicity Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,683.08
    4,024.62
    5,366.16
    3,222.48
    4,833.72
    6,444.96
    533,275.20
    799,912.80
    1,066,550.40
    293,468.40
    440,202.60
    586,936.80
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report